| 期刊簡介 | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | Molecular Cancer LetPub Score 8.5
52 ratings
Rate
Reputation 8.6 Influence 8.3 Speed 8.7 | ||||||||||||||||||||||||
| 期刊簡稱 | MOL CANCER | ||||||||||||||||||||||||
| ISSN | 1476-4598 | ||||||||||||||||||||||||
| h-index | 103 | ||||||||||||||||||||||||
| CiteScore |
| ||||||||||||||||||||||||
| 自引率 (2023-2024) | 2.20%自引率趨勢 | ||||||||||||||||||||||||
| 掲載範囲 |
| ||||||||||||||||||||||||
| 官方網站 | http://molecular-cancer.biomedcentral.com | ||||||||||||||||||||||||
| 在線稿件提交 | https://submission.nature.com/new-submission/12943/3 | ||||||||||||||||||||||||
| 開放訪問 | Yes | ||||||||||||||||||||||||
| 出版商 | BioMed Central | ||||||||||||||||||||||||
| 主題領域 | 医学 | ||||||||||||||||||||||||
| 出版國/地區 | ENGLAND | ||||||||||||||||||||||||
| 發行頻率 | 月刊 | ||||||||||||||||||||||||
| 創刊年 | 2002 | ||||||||||||||||||||||||
| 每年文章數 | 218每年文章數趨勢 | ||||||||||||||||||||||||
| 黃金OA百分比 | 100.00% | ||||||||||||||||||||||||
OA Related Info![]() | APC: Yes( EUR3990; USD4890; GBP3490; ) APC waiver:Check Notes Other charges: No Keywords: oncology、tumour biology、cancer antigens Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | ||||||||||||||||||||||||
| Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||||||||||
| 索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||||||
| 鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1476-4598%5BISSN%5D | ||||||||||||||||||||||||
| 平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Average 2 Month(s) | ||||||||||||||||||||||||
| 競爭力 * | 來自作者的數據: About 50% | ||||||||||||||||||||||||
| 參考鏈接 |
| ||||||||||||||||||||||||
| *所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 | |||||||||||||||||||||||||
|
|
| |
| 首頁 上一頁 32 33 34 35 36 37 38 下一頁 末頁 (頁 | |
| [Molecular Cancer] 的評論 | 撰寫評論 |
| 作者: 东京君博 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-10-29 09:52:12 評論於 Can I submit an article on purebred dogs to this magazine? |
| 作者: 飞月芷枫 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-09-21 17:04:56 評論於 Depending on the situation, sometimes it takes about a month and a half to find a reviewer |
| 作者: 佛光焦铭 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-09-11 17:16:05 評論於 Dear experts, I would like to ask for some advice. When I was submitting my article for publication, I encountered an error after the final step of "building PDF". I tried several times and even changed browsers, but it still didn't work. What could be the reason for this? |
| 作者: 黑山丽萍 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-09-03 21:16:31 評論於 How long does the first review of this magazine take? |
| 作者: 重阳布衣 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-08-15 08:10:00 評論於 It's normal not to be able to find, I'm a PhD student and I've reviewed for Molecular Cancer and JECCR. I accepted two articles previously. Yesterday the date was updated again and reviewers were assigned, this is the third time. Strange. Can't find reviewers? |
| 作者: 飞月芷枫 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-07-08 11:19:55 評論於 Yesterday the deadline was updated again. Reviewers are still assigned, this is the third time. Strange. Can't find reviewers? |
| 作者: 飞月芷枫 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-07-06 11:36:18 評論於 How long have you been under review? |
| 作者: 飞月芷枫 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-07-05 16:25:11 評論於 So slow! sunliang 2018-07-03 00:00:00 发表:This magazine. Hasn't been updated. According to your experience, the efficiency seems to be low |
| 作者: 白云盼山 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-07-03 17:43:40 評論於 Review Speed: 3.0 | Submission Acceptance Rate: 25.0 Experience Sharing: Few articles published every year, high rejection rate |
| 作者: 重阳文景 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-07-03 16:28:05 評論於 This magazine has never been submitted. It seems that the efficiency is relatively low according to your experience |
| 作者: 飞月芷枫 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-06-21 20:36:07 評論於 How long is your editor assigned to under review? |
| 作者: 飞月芷枫 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-06-21 17:06:12 評論於 Hello. How is your article going? How long does it usually take for an editor assigned to review it? |
| 作者: 飞月芷枫 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-06-21 15:14:58 評論於 How long does your editor assign take to be under review? |
| 作者: 飞月芷枫 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-06-21 09:34:12 評論於 Hello. How is your article going? I submitted it two weeks ago and it was assigned to a reviewer, but then it was changed back to an editor. It has been three weeks now and it is still with the editor. Do you know how long it normally takes for this journal to be under review? |
| 作者: 飞月芷枫 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-06-06 10:21:10 評論於 How long does it take for the editor assigned after submitting to Molecular Cancer? It's been a week and my editor assigned hasn't changed, what's going on? |
| 作者: 雨巷少年素云 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-05-23 16:18:40 評論於 Can anyone tell me if the major revision will be sent back to the original reviewer? How long does it typically take to hear back after submitting revisions? Thank you |
| 作者: 雨巷少年素云 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-04-10 08:11:27 評論於 I would like to ask you experts, the first revision has the comments of two reviewers, and the magazine's language polishing content. After I completed the experiment, I sent it to them again, and the next day they revised it again for me. Besides the reviewers' comments, everything else is exactly the same as the first time, only the language polishing is left. What does this mean? Are they asking me to polish the language according to their website? Thank you |
| 作者: 东海长永 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-03-26 23:41:57 評論於 Is the review time long? Is the acceptance rate high for reviews? 1095307958_88362497 2018-03-21 Published: I published a review in 2017. The layout fee is approximately 15000 RMB |
| 作者: 百花友凡 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-03-23 09:23:50 評論於 Yuyu. May I ask how long your editor assigned took? |
| 作者: 百花又松 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-03-22 16:29:55 評論於 Review speed: 2.0 | Submission hit rate: 50.0 Experience sharing: Submitted on February 1st. The speed of receiving the OA today is faster than expected. It may be because the chosen topic direction is more in line with the taste of the editor-in-chief. Review on exosomes |
| 作者: 海阳mio 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-03-22 15:26:54 評論於 Real-time 5.67 |
| 作者: 神照冬雪 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-03-21 14:20:49 評論於 Published a review article in 2017, and the page fee is around 15,000 RMB |
| 作者: 百花友凡 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-03-19 23:51:38 評論於 How is it going with you now? The editor assigned my paper at the end of last month. The date has been changed once on the 4th. gangyang_wang_52029606 2018-02-20 post:: Research direction: targeted therapy; tumor metastasis; angiogenesis. Acceptance rate: about 25% Review time: about 2 months It has been a month and it is still editor assigned. The date was changed once in the middle. Can anyone tell me why it is so slow? Is the rejection rate high? |
| 作者: 排云灵慧 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-03-15 22:51:17 評論於 Normal. Estimated February gangyang_wang_52029606 Posted: 2018-02-20 Research direction: Targeted therapy; Tumor metastasis; Angiogenesis acceptance rate: about 25% Review time: about 2 months It has been a month or editor assigned in the middle of the date. Can anyone tell me why is it so slow? Is the rejection rate high? |
| 作者: 百花又松 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-02-23 10:41:23 評論於 Review Speed: 1.0 Experience Sharing: I want to ask if there is a major revision in the revised version, one reviewer basically agrees without the need for modification, and the other reviewer feels that the tone is not very friendly. Will the editor pay more attention to the final result? |
| 首頁 上一頁 32 33 34 35 36 37 38 下一頁 末頁 (頁 | |
Contact us